208 related articles for article (PubMed ID: 29453304)
1. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
Hall CL; James M; Brown S; Martin JL; Brown N; Selby K; Clarke J; Vijayan H; Guo B; Sayal K; Hollis C; Groom MJ
BMJ Open; 2018 Feb; 8(2):e021104. PubMed ID: 29453304
[TBL] [Abstract][Full Text] [Related]
2. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial.
Hall CL; Walker GM; Valentine AZ; Guo B; Kaylor-Hughes C; James M; Daley D; Sayal K; Hollis C
BMJ Open; 2014 Dec; 4(12):e006838. PubMed ID: 25448628
[TBL] [Abstract][Full Text] [Related]
3. Optimising medication management in children and young people with ADHD using a computerised test (QbTest): a feasibility randomised controlled trial.
Williams L; Hall CL; Brown S; Guo B; James M; Franceschini M; Clarke J; Selby K; Vijayan H; Kulkarni N; Brown N; Sayal K; Hollis C; Groom MJ
Pilot Feasibility Stud; 2021 Mar; 7(1):68. PubMed ID: 33726855
[TBL] [Abstract][Full Text] [Related]
4. Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach.
Hall CL; Valentine AZ; Walker GM; Ball HM; Cogger H; Daley D; Groom MJ; Sayal K; Hollis C
BMC Psychiatry; 2017 Feb; 17(1):66. PubMed ID: 28183284
[TBL] [Abstract][Full Text] [Related]
5. Using an objective computer task (QbTest) to aid the identification of attention deficit hyperactivity disorder (ADHD) in the Children and Young People Secure Estate (CYPSE): a feasibility randomised controlled trial.
Chitsabesan P; Hall CL; Carter LA; Reeves M; Mohammed V; Beresford B; Young S; Kraam A; Trowse S; Wilkinson-Cunningham L; Lennox C
BMJ Open; 2022 Dec; 12(12):e064951. PubMed ID: 36526320
[TBL] [Abstract][Full Text] [Related]
6. Objective QbTest and subjective evaluation of stimulant treatment in adult attention deficit-hyperactivity disorder.
Bijlenga D; Jasperse M; Gehlhaar SK; Sandra Kooij JJ
Eur Psychiatry; 2015 Jan; 30(1):179-85. PubMed ID: 25172155
[TBL] [Abstract][Full Text] [Related]
7. FACT: a randomised controlled trial to assess the feasibility of QbTest in the assessment process of attention deficit hyperactivity disorder (ADHD) for young people in prison-a feasibility trial protocol.
Lennox C; Hall CL; Carter LA; Beresford B; Young S; Kraam A; Brown N; Wilkinson-Cunningham L; Reeves M; Chitsabesan P
BMJ Open; 2020 Jan; 10(1):e035519. PubMed ID: 31964678
[TBL] [Abstract][Full Text] [Related]
8. The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial.
Hollis C; Hall CL; Guo B; James M; Boadu J; Groom MJ; Brown N; Kaylor-Hughes C; Moldavsky M; Valentine AZ; Walker GM; Daley D; Sayal K; Morriss R;
J Child Psychol Psychiatry; 2018 Dec; 59(12):1298-1308. PubMed ID: 29700813
[TBL] [Abstract][Full Text] [Related]
9. Consensus workshops on the development of an ADHD medication management protocol using QbTest: developing a clinical trial protocol with multidisciplinary stakeholders.
Hall CL; Brown S; James M; Martin JL; Brown N; Selby K; Clarke J; Williams L; Sayal K; Hollis C; Groom MJ
BMC Med Res Methodol; 2019 Jun; 19(1):126. PubMed ID: 31215440
[TBL] [Abstract][Full Text] [Related]
10. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
11. Monitoring medication response in ADHD: what can continuous performance tests tell us?
Cedergren K; Östlund S; Åsberg Johnels J; Billstedt E; Johnson M
Eur Arch Psychiatry Clin Neurosci; 2022 Mar; 272(2):291-299. PubMed ID: 34420075
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
13. ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents.
Stevanovic D; Wentz E; Nasic S; Knez R
BMC Psychiatry; 2022 Apr; 22(1):282. PubMed ID: 35448977
[TBL] [Abstract][Full Text] [Related]
14. Innovations in Practice: an objective measure of attention, impulsivity and activity reduces time to confirm attention deficit/hyperactivity disorder diagnosis in children - a completed audit cycle.
Hall CL; Selby K; Guo B; Valentine AZ; Walker GM; Hollis C
Child Adolesc Ment Health; 2016 Sep; 21(3):175-178. PubMed ID: 32680350
[TBL] [Abstract][Full Text] [Related]
15. Incremental clinical utility of continuous performance tests in childhood ADHD - an evidence-based assessment approach.
Tallberg P; Råstam M; Wenhov L; Eliasson G; Gustafsson P
Scand J Psychol; 2019 Feb; 60(1):26-35. PubMed ID: 30452083
[TBL] [Abstract][Full Text] [Related]
16. Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol.
Mundal I; Gråwe RW; Hafstad H; De Las Cuevas C; Lara-Cabrera ML
BMJ Open; 2020 Dec; 10(12):e039852. PubMed ID: 33268416
[TBL] [Abstract][Full Text] [Related]
17. ADHD and the QbTest: Diagnostic Validity of QbTest.
Hult N; Kadesjö J; Kadesjö B; Gillberg C; Billstedt E
J Atten Disord; 2018 Sep; 22(11):1074-1080. PubMed ID: 26224575
[TBL] [Abstract][Full Text] [Related]
18. Objective assessment of attention-deficit/hyperactivity disorder in older adults compared with controls using the QbTest.
Bijlenga D; Ulberstad F; Thorell LB; Christiansen H; Hirsch O; Kooij JJS
Int J Geriatr Psychiatry; 2019 Oct; 34(10):1526-1533. PubMed ID: 31243809
[TBL] [Abstract][Full Text] [Related]
19. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
[TBL] [Abstract][Full Text] [Related]
20. Fetal alcohol spectrum disorder and attention deficit hyperactivity disorder stimulant trial in children: an N-of-1 pilot trial to compare stimulant to placebo (FASST): protocol.
Crichton A; Harris K; McGree JM; Nikles J; Anderson PJ; Williams K
BMJ Open; 2024 Apr; 14(4):e071266. PubMed ID: 38631835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
